Canopy Growth Corporation · TSX:WEED
Canopy Growth — Investor Presentation (February 2019)
22 slides from Canopy Growth's investor presentation, February 2019
Slide 1: Driving the Global Cannabis Industry
DRIVING THE GLOBAL CANNABIS INDUSTRY February 2019
Slide 2: Forward-Looking Statement
FORWARD-LOOKING STATEMENT This presentation contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “Forward-Looking State
Slide 3: Company Snapshot
COMPANY SNAPSHOT Canopy Growth (TSX:WEED) (NYSE: CGC) is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Share Price Performance (TSX:WEED) $80 $70 Operations in over a dozen countries Cannabis me
Slide 4: Leading the Canadian Cannabis Market
LEADING THE CANADIAN CANNABIS MARKET
Slide 5: Canadian Medical Market Leader
CANADIAN MEDICAL MARKET LEADER • 85,000+ Patients • 56,000+ Healthcare Professional Visits1 • Certified Medical Education Program • Exclusive Pharmacy Learning Modules Accredited by Canadian Pharmacy Association and CCCEP2 • Peer Catalyst Mentor Program • Pilot Program w/ Ontario Long Term Care Asso
Slide 6: Canadian Recreational Market Leader
CANADIAN RECREATIONAL MARKET LEADER 30%+ 70,000+ Share of SKUs Available Nationwide1 kg/yr Minimum Supply Commitments2 Leading Market Share Position Achieved Nationwide 1. 2. Estimate, December 7, 2018, based on available SKU data Minimum supply commitment from 10 agreements signed to date, excludin
Slide 7: Engaging Retail – Build Brand, Build Demand
ENGAGING RETAIL – BUILD BRAND, BUILD DEMAND Brick & Mortar1 Online Government Private Hybrid 8 In Process 5 15 In Process Technology-enabled, Nationwide sales force 1 Store count includes Tweed and Tokyo Smoke locations 7
Slide 8: Recreational Market Leader – Physical Retail Builds Brands
RECREATIONAL MARKET LEADER – PHYSICAL RETAIL BUILDS BRANDS 8
Slide 9: Recreational Market Leader – Physical Retail Builds Brands
RECREATIONAL MARKET LEADER – PHYSICAL RETAIL BUILDS BRANDS 9
Slide 10: It's Not Just About the Plant, It's About a Potentially Disruptive Ingredient
IT’S NOT JUST ABOUT THE PLANT, IT’S ABOUT A POTENTIALLY DISRUPTIVE INGREDIENT ILLICIT MARKET CONVERSION POTENTIAL GLOBAL MARKET DISRUPTION - $500B+ TARGET MARKETS INCLUDE: CANADA CANADA INTERNATIONAL ATHLETIC DRINKS4 $40B MEDICAL1 REC.2 MEDICAL3 ANIMAL HEALTH5 $50B $3B $5B - $9B $180B PAIN RELIEF6 $
Slide 11: Cannabis – A Potentially Disruptive Ingredient
CANNABIS – A POTENTIALLY DISRUPTIVE INGREDIENT SCIENCE-BASED, NO ALCOHOL CLINICALLY-PROVEN OUTCOMES NO CALORIES ANTI-INFLAMMATION NO HANGOVER ANTI-ANXIETY HAPPY LIVER Value-added products expected to enter Canadian recreational cannabis market in Q4 CY2019 11
Slide 12: Digging Our Economic Moat
DIGGING OUR ECONOMIC MOAT gh Fp, 6 71 Spectrum Cannabis:
Slide 13: Developing Cannabis-Based Beverages – 2+ Year R&D Program
DEVELOPING CANNABIS-BASED BEVERAGES – 2+ YEAR R&D PROGRAM GOALS OUTCOME • Calorie free Formulation developed using • Transparent all natural ingredients with a • Fast onset unique process order that • Long shelf life creates a stable, cannabinoid • Compatible with a variety of containing, optically
Slide 14: Canopy Health Innovations
CANOPY HEALTH INNOVATIONS Developing safe, effective cannabis medicines RESEARCH PROGRAM1 43 PATENT APPLICATIONS FILED WITH USPTO2 15 HUMAN HEALTH CLINICAL TRIALS INCLUDING PHASE IIB SLEEP TRIALS3 4 ANIMAL HEALTH CLINICAL TRIALS INCLUDING COMPANION ANIMAL ANXIETY 1 Includes trials underway or planne
Slide 15: Growing IP Portfolio
GROWING IP PORTFOLIO XXXX Image of gas lamp type 140+ PATENT APPLICATIONS FILED TO DATE, light bulb (bad example below) MANY MORE UNDER DEVELOPMENT • Cannabis-based beverage production • Cannabis-based medical treatments • Device & delivery technologies • Large-scale cannabis processing • Cannabis p
Slide 16: Canopy Innovation Driving the World
CANOPY INNOVATION DRIVING THE WORLD
Slide 17: The Legalization of Cannabis Is Spreading Globally
THE LEGALIZATION OF CANNABIS IS SPREADING GLOBALLY Medical & Adult-Use Legalized Medical Use Legalized In the Process of Legalizing Medical Use / Exploring Legalization Industrial Hemp legalized – Path for Canopy Growth to enter US market 17
Slide 18: Driving Global Growth
DRIVING GLOBAL GROWTH » | os, 3, Spectrum | et 6 Cannabis 18
Slide 19: $5 Billion Investment to Accelerate Global Growth Plans
INVESTMENT TO ACCELERATE GLOBAL GROWTH PLANS $5 BILLION USE OF PROCEEDS: • Expansion in Europe & South America • Entry Into United States • R&D Support • Mergers & Acquisitions 19
Slide 20: Management Team
MANAGEMENT TEAM Bruce Linton Mark Zekulin Tim Saunders Dr. Mark Ware Chairman & Co-CEO President & Co-CEO EVP & Chief Financial Officer Chief Medical Officer 20
Slide 21: Management Team
MANAGEMENT TEAM Phil Shaer Amanda Daley Rade Kovacevic Dave Bigioni Chief Legal Officer VP, Medical Sales & Education Executive Vice President Chief Commercial Officer 21
Slide 22: Performance Highlights
PERFORMANCE HIGHLIGHTS Revenue (M) Sales (kg & kg equiv.) $25.9 $22.8 $23.3 2,695 $21.7 2,528 2,330 2,197 $17.6 2,020 Q218 Q318 Q418 Q119 Q219 Q218 Q318 Q418 Q119 Q219 Avg. Sales Price per Gram Patients $10 $9.87 85,000 84,400 74,000 $8.94 69,000 64,000 $8.43 $8.30 $7.99 $8 $6 Q218 Q318 Q418 Q119 Q2
Canopy Growth — Investor Presentation (February 2019) on 6ix